Reuters reported exclusively that private equity-backed generic drugmaker Stada said it has agreed to buy 15 consumer healthcare products from British drugmaker GlaxoSmithKline to further strengthen its prescription-free drugs business in Europe. The brands â€“ venous treatment Venoruton, Coldrex cold remedy, Cetebe vitamin C supplements, Mebucaine for sore throats and Tavegyl allergy relief, among others â€“ are marketed in more than 40 countries. Stada agreed to pay more than 300 million euros ($325 million), Reuters sources said.
Reuters exclusively reports Germany’s Stada buys 15 GSK consumer health brands
24 February 2020, 12:00 am. 1 minute
More of Reuters Best
Reuters exclusively reports Indian sugar mills to close early as rain hits cane supply; sugar futures jump; shares fall
January 29, 2023
January 27, 2023
January 25, 2023